News
MIAMI, March 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), ("SAB BIO" or the "Company"), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing ...
Nippon India Power & Infra Fund (G) 2.44 16,53,747 0.15 Nippon India Power & Infra Fund (Bonus) 2.44 16,53,747 0.15 Nippon India Power & Infra Fund - Direct (G) 2.44 16,53,747 0.15 Edelweiss Balanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback